Simulations Plus, Inc. Logo

Simulations Plus, Inc.

Modeling & simulation software and consulting for pharma/biotech to accelerate drug development.

SLP | US

Overview

Corporate Details

ISIN(s):
US8292141053
LEI:
Country:
United States of America
Address:
800 PARK OFFICES DRIVE, SUITE 401, 27709 RESEARCH TRIANGLE PARK
Sector:
Mining and quarrying
Industry:
Mining of non-ferrous metal ores

Description

Simulations Plus, Inc. is a leading provider of modeling and simulation software and consulting services for the pharmaceutical, biotechnology, and other science-based industries. The company specializes in solutions that support drug discovery and development, from early research and clinical development to regulatory submissions. Its flagship products, including GastroPlus® and ADMET Predictor®, utilize advanced technologies like AI/machine learning, physiologically based pharmacokinetic (PBPK), quantitative systems pharmacology (QSP), and quantitative systems toxicology (QST) modeling. These tools enable scientists to predict the properties and effects of chemical and biological compounds, helping to optimize drug design, predict safety and efficacy, and accelerate the development timeline. The company serves a global client base, including major pharmaceutical companies, regulatory agencies, and academic institutions.

Unlock This Filing & Millions More

You're one step away from the data you need. Create a free account to instantly view this filing and get access to powerful research tools.

Filings

You have of free filing views remaining. Upgrade for unlimited access.
Quick Filters:

Filters

Clear
Bulk Actions:
Date Filing Language Size Actions
No filings match the current criteria.

Automate Your Workflow. Get a real-time feed of all Simulations Plus, Inc. filings delivered via API.

Explore Data Feeds →

Market Data

Market Data Not Available

Financials & KPIs

No data available

Unlock Full Financials for Simulations Plus, Inc.

This data is available as part of our premium data solutions. Contact our team for access.

Need More History? Access decades of standardized financials for Simulations Plus, Inc. via our API.

Get Historical Data →

Insider Transactions

Date Insider Name Position Type Shares Value
No insider transactions recorded for this company.

Peer Companies

Company Country Ticker View
Virax Biolabs Group Ltd Logo
Specializes in T-cell immunity tests and diagnostics for profiling viral disease responses.
United States of America VRAX
VisionSys AI Inc Logo
Develops AI-powered brain-computer interfaces for the healthcare and biotech sectors.
United States of America VSA
Vivesto Logo
Develops and licenses novel cancer therapies for humans and animals using proprietary drug delivery.
Sweden VIVE
Vor Biopharma Inc. Logo
Clinical-stage biotech developing next-gen medicines that target the root cause of autoimmune disease.
United States of America VOR
Voronoi, Inc. Logo
Develops selective kinase inhibitors and targeted protein degraders for precision oncology.
South Korea 310210
Voyager Therapeutics, Inc. Logo
Developing AAV gene therapies for neurological diseases like Alzheimer's, ALS, and Parkinson's.
United States of America VYGR
VS MEDIA Holdings Ltd Logo
A global media network connecting creators and brands for data-driven social commerce.
United States of America VSME
WDB coco CO.,LTD. Logo
CRO for pharma & med devices specializing in safety info, PMS & full lifecycle support.
Japan 7079
WDB HOLDINGS CO.,LTD. Logo
Provides specialized staffing, contract research (CRO) services, and related digital platforms.
Japan 2475
WEATHERNEWS INC. Logo
Global weather data & risk solutions for B2B (sea, air, land) and consumer apps.
Japan 4825

Talk to a Data Expert

Have a question? We'll get back to you promptly.